Cargando…

Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME

AIM: To counteract/reveal celecoxib-induced toxicity and NO system involvement. METHODS: Celecoxib (1 g/kg b.w. ip) was combined with therapy with stable gastric pentadecapeptide BPC 157 (known to inhibit these lesions, 10 μg/kg, 10 ng/kg, or 1 ng/kg ip) and L-arginine (100 mg/kg ip), as well as NOS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drmic, Domagoj, Kolenc, Danijela, Ilic, Spomenko, Bauk, Lara, Sever, Marko, Zenko Sever, Anita, Luetic, Kresimir, Suran, Jelena, Seiwerth, Sven, Sikiric, Predrag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550779/ https://www.ncbi.nlm.nih.gov/pubmed/28839430 http://dx.doi.org/10.3748/wjg.v23.i29.5304

Ejemplares similares

Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME
por: Djakovic, Zeljko, et al.
Publicado: (2016)

Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine
por: Stupnisek, Mirjana, et al.
Publicado: (2015)

Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats
por: Lojo, Nermin, et al.
Publicado: (2016)

Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats
por: Rasic, Domagoj, et al.
Publicado: (2021)

Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine
por: Drmic, Domagoj, et al.
Publicado: (2018)

Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats
por: Jandric, Ivan, et al.
Publicado: (2013)

Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats
por: Perovic, Darko, et al.
Publicado: (2019)

The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats
por: Vukojević, Jakša, et al.
Publicado: (2020)

In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro
por: Lozic, Marin, et al.
Publicado: (2020)

Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats
por: Cesar, Lidija Berkopic, et al.
Publicado: (2020)

BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats
por: Zlatar, Mirna, et al.
Publicado: (2021)

Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
por: Sikiric, Predrag, et al.
Publicado: (2016)

Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot
por: Konosic, Sanja, et al.
Publicado: (2019)

Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal
por: Udovicic, Mario, et al.
Publicado: (2021)

Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats
por: Barisic, Ivan, et al.
Publicado: (2022)

Over-Dose Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157
por: Strbe, Sanja, et al.
Publicado: (2021)

Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights
por: Duzel, Antonija, et al.
Publicado: (2017)

Pentadecapeptide BPC 157 and the central nervous system
por: Vukojević, Jakša, et al.
Publicado: (2021)

Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
por: Amic, Fedor, et al.
Publicado: (2018)

BPC 157 Therapy and the Permanent Occlusion of the Superior Sagittal Sinus in Rat: Vascular Recruitment
por: Gojkovic, Slaven, et al.
Publicado: (2021)

Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats
por: Mirković, Ivan, et al.
Publicado: (2020)

BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling “Negative-Like” Symptoms of Schizophrenia
por: Zemba Cilic, Andrea, et al.
Publicado: (2022)

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
por: Seiwerth, Sven, et al.
Publicado: (2021)

Robert’s Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157
por: Gojkovic, Slaven, et al.
Publicado: (2021)

Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats
por: Japjec, Mladen, et al.
Publicado: (2021)

Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157
por: Knezevic, Mario, et al.
Publicado: (2021)

Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future
por: Sikiric, Predrag, et al.
Publicado: (2020)

Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats
por: Gojkovic, Slaven, et al.
Publicado: (2020)

Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma
por: Kralj, Tamara, et al.
Publicado: (2021)

Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension
por: Knezevic, Mario, et al.
Publicado: (2021)

Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide BPC 157 in Rats
por: Knezevic, Mario, et al.
Publicado: (2021)

Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle
por: Staresinic, Mario, et al.
Publicado: (2022)

Physiological and Immunological Status of Adult Honeybees (Apis mellifera) Fed Sugar Syrup Supplemented with Pentadecapeptide BPC 157
por: Tlak Gajger, Ivana, et al.
Publicado: (2021)

Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect
por: Kalogjera, Luka, et al.
Publicado: (2023)

Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
por: Tepes, Marijan, et al.
Publicado: (2021)

Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats
por: Smoday, Ivan Maria, et al.
Publicado: (2023)

Stable Gastric Pentadecapeptide BPC 157 May Recover Brain–Gut Axis and Gut–Brain Axis Function
por: Sikiric, Predrag, et al.
Publicado: (2023)

Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
por: Tepes, Marijan, et al.
Publicado: (2022)

Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions
por: Sikiric, Predrag, et al.
Publicado: (2023)

Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome
por: Sikiric, Predrag, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mkf2frasj9jtipsvoav1gm5i1i